| 2012 | | A compound (DW1182v) protecting high glucose/palmitate-induced glucolipotoxicity to INS-1 beta cells preserves islet integrity and improves hyperglycemia in obese db/db mouse | 강엽, 김대중, 김혜진, 이관우, 한승진 |
| 2024 | | A Multicenter, Randomized, Open-Label Study to Compare the Effects of Gemigliptin Add-on or Escalation of Metformin Dose on Glycemic Control and Safety in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Treated with Metformin and SGLT-2 Inhibitors (SO GOOD Study) | 김혜진 |
| 2020 | | A New Objective Health Numeracy Test for Patients with Type 2 Diabetes: Development and Evaluation of Psychometric Properties | 이관우, 이은현 |
| 2015 | | A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes. | 이관우 |
| 2016 | | Association between blood glucose level derived using the oral glucose tolerance test and glycated hemoglobin level | 김대중, 김형주, 하경화 |
| 2016 | | Basal-prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24-week randomized non-inferiority trial | 이관우 |
| 2013 | | Beneficial effects of fresh and fermented kimchi in prediabetic individuals. | 김대중, 김혜진, 이관우, 전자영, 한승진 |
| 2020 | | Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study | 김대중, 하경화 |
| 2018 | | Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study | 김대중 |
| 2021 | | Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data | 김대중 |
| 2014 | | Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the Republic of Korea. | 김대중, 김혜진, 이관우, 전기홍, 전자영, 한승진 |
| 2019 | | Clinical characteristics of diabetic ketoacidosis in users and non-users of SGLT2 inhibitors | 김대중, 전자영 |
| 2007 | | Clinical characteristics of Korean type 2 diabetic patients in 2005. | 김대중, 이관우 |
| 2022 | | Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study | 김혜진 |
| 2016 | | Comparison of screening scores for diabetes and prediabetes | 김대중 |
| 2006 | | Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. | 김대중, 김혜진, 이관우, 정윤석 |
| 2007 | | Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model. | 김대중, 김혜진, 이관우 |
| 2019 | | Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status | 김대중, 하경화 |
| 2013 | | Differential significance of plasma visfatin concentrations according to adiposity in children and adolescents. | 김대중, 김혜진, 이관우, 최용준, 한승진 |
| 2010 | | Does abdominal obesity accelerate the effect of hypertriglyceridemia on impaired fasting glucose? | 김대중, 이순영, 전기홍 |
| 2006 | | Does birthweight predict adolescent adiponectin levels? | 김대중 |
| 2023 | | Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study | 이관우 |
| 2007 | | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. | 김대중, 이관우 |
| 2017 | | Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study) | 이관우 |
| 2018 | | Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial | 이관우 |
| 2019 | | Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial | 이관우 |
| 2011 | | Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. | 김혜진 |
| 2011 | | Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients. | 김대중, 김혜진, 안소연, 이관우, 이민석, 한승진 |
| 1997 | | Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. | 강엽, 윤지원 |
| 2014 | | Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: the fifth Korea National Health and Nutrition Examination Survey (2011). | 김대중 |
| 2015 | | Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. | 이관우 |
| 2017 | | Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study | 김대중, 김혜진, 이관우, 조남한, 한승진 |
| 2011 | | Intake of brown rice lees reduces waist circumference and improves metabolic parameters in type 2 diabetes. | 김대중, 김혜진, 이관우, 이민석, 한승진 |
| 2011 | | Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes. | 강엽, 김대중, 김혜진, 이관우, 최용준, 한승진 |
| 2015 | | Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension. | 이관우 |
| 2018 | | Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence | 하경화 |
| 2015 | | Paradoxical Associations of Insulin Resistance With Total and Cardiovascular Mortality in Humans. | 김대중 |
| 2015 | | Performance of HbA1c for the prediction of diabetes in a rural community in Korea. | 김대중 |
| 2005 | | Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus. | 김대중 |
| 2006 | | Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. | 김대중 |
| 2015 | | PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. | 김대중 |
| 2020 | | Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study | 김대중 |
| 2021 | | Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study | 정윤석 |
| 2014 | | Serum magnesium level is associated with type 2 diabetes in women with a history of gestational diabetes mellitus: the Korea National Diabetes Program study. | 이관우 |
| 2013 | | Sleep duration and glycemic control in patients with diabetes mellitus: Korea National Health and Nutrition Examination Survey 2007-2010. | 김대중, 이관우, 정윤석, 최용준, 한승진 |
| 2016 | | Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database | 박래웅, 신승수, 윤덕용, 임홍석, 최용준 |
| 2006 | | The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. | 김혜진 |
| 2022 | | The Degree of Glycemic Control for the First Three Months Determines the Next Seven Years | 김대중, 이나미 |
| 2007 | | The diagnosis of diabetes mellitus in Korea: a pooled analysis of four community-based cohort studies. | 김대중 |
| 2006 | | The effects of Goami No. 2 rice, a natural fiber-rich rice, on body weight and lipid metabolism. | 김대중, 김연경, 이관우 |
| 2007 | | The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment. | 김혜진 |
| 2006 | | The long-term effects of rosiglitazone on serum lipid concentrations and body weight. | 김혜진 |
| 2021 | | Time to reach target glycosylated hemoglobin is associated with long-term durable glycemic control and risk of Diabetic complications in patients with newly diagnosed Type 2 Diabetes mellitus: A 6-year observational study (Diabetes Metab J 2021;45:368-78) | 전자영 |
| 2012 | | β-Cell-protective effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid as a glutamate dehydrogenase activator in db/db mice | 강엽, 김대중, 김혜진, 이관우, 한승진 |
